share_log

Procaps Group (NASDAQ:PROC) Shares Gap Up to $4.73

Financial News Live ·  Jan 12, 2023 10:52

Procaps Group S.A. (NASDAQ:PROC – Get Rating) shares gapped up before the market opened on Thursday . The stock had previously closed at $4.73, but opened at $5.15. Procaps Group shares last traded at $5.13, with a volume of 300 shares trading hands.

Procaps Group Trading Up 5.7 %

The stock's 50-day moving average is $6.10 and its 200 day moving average is $7.08.

Get Procaps Group alerts:

Procaps Group (NASDAQ:PROC – Get Rating) last announced its quarterly earnings data on Monday, November 14th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.09. Procaps Group had a net margin of 13.82% and a negative return on equity of 243.60%. The firm had revenue of $110.40 million for the quarter, compared to the consensus estimate of $123.90 million. As a group, equities analysts anticipate that Procaps Group S.A. will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PROC. Millennium Management LLC grew its position in Procaps Group by 15.9% during the second quarter. Millennium Management LLC now owns 101,430 shares of the company's stock valued at $945,000 after purchasing an additional 13,908 shares in the last quarter. Citadel Advisors LLC bought a new stake in Procaps Group in the second quarter worth approximately $263,000. Finally, State Street Corp bought a new stake in Procaps Group in the third quarter worth approximately $89,000. 0.95% of the stock is owned by hedge funds and other institutional investors.

About Procaps Group

(Get Rating)

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.

Featured Articles

  • Get a free copy of the StockNews.com research report on Procaps Group (PROC)
  • Is The Great Alibaba Recovery About To Begin?
  • KB Home, Another Reason To Shed Home Building Stocks
  • Is Wendy's Stock Uptrend Set To Continue?
  • Altria Group Stock, Is Time is Running Out?
  • Why Did the JinkoSolar Stock Price Rally 45%?

Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment